FARM5210 – Novel Drug Delivery Systems (NDDS)
Schedule, syllabus and examination date
Changes in the course due to coronavirus
Autumn 2020 and Spring 2021 the exams of most courses at the MN Faculty will be conducted as digital home exams or oral exams, using the normal grading scale. The semester page for your course will be updated with any changes in the form of examination.
Please note that there may be changes in the form of examination for some courses taught Spring 2021. We aim to bring both the course description and the semester page of all courses up to date with correct information by 1 February 2021.
Novel drug delivery systems (NDDS) include formulations, delivery systems and technology required for site-specific drug delivery in order to optimize pharmacological effects and reduce side effects. The course will focus on development of NDDS and includes both small molecular drugs and biomolecules. Regulatory aspects related to the selected devices will be discussed.
After completing the course
- you will have deep knowledge about the application of nanoparticles, bio conjugates, gels, and implants in drug delivery. Further, you will have a deep knowledge about novel technologies (e.g. theranostics, photochemical internalization) in drug targeting and in delivery of biomolecular drugs.
- you will have deep knowledge about in vitro challenges (e.g. drug load, solubility, stability, release profile) related to NDDS.
- You will have deep knowledge about in vivo challenges (e.g. biological barriers, physiological properties at the administration site, side effects, toxicology) related to NDDS.
- you will be able to discuss regulatory issues related to "quality and safety" upon application of NDDS.
- you will be able to work in a team, and prepare and present an overview on approaches for development of drug delivery systems for specific APIs.
- you will be able to communicate and discuss drug formulation aspects in a scientific forum.
Admission to the course
The course is primarily open to students who have been admitted to the Department of Pharmacy at the University of Oslo. If there is space available then others may also apply to take the course as long as their academic background is adequate.
Formal prerequisite knowledge
the compulsory parts of FARM4100 – Personalised Drug Therapy
the compulsory parts of FARM4110 – Comprehensive Biopharmacy and Formulation Technology
the compulsory parts of FARM4120 – Drug Development
the compulsory HMS-courses HMS0501 – Safety and Physical Environment, HMS0502 – Positive Learning Environment, HMS0503 – Laboratory Safety, HMS0506 – Patient Clinic Safety and HMS0507 – Fire Safety required for students at the 5-year Master`s Program in Pharmacy.
For students admitted to the 5-year Master`s Program in Pharmacy until and including 2016 and who have been transferred from the old study plan, separate formal prerequisite knowledge apply. These are in professional compliance with the formal prerequisite knowledge that apply to the course, but may be replaced by courses from the old study plan, as well as transitional courses. Students on transitional arrangements may contact the study administration for å complete overview of the formal prerequisite knowledge required.
The course is only available to students who have passed their pharmacy apprenticeship and have passed all previous pharmacy courses or have the equivalent academic background.
Recommended previous knowledge
- 10 credits overlap with FRM5530 – Drug Formulation, Drug Targeting.
- 2 hours introduction (obligatory)
- 4 hours team work under supervision
- 15 hours team work in combination with flipped classroom to prepare mini lectures and poster
- 4 hours mini lectures (obligatory, pass/fail evaluation)
- 2 hours poster presentation (obligatory, pass/fail evaluation)
- 3 hours visit to pharmaceutical industry or similar (obligatory)
There is a compulsory attendance for the first information lecture. Students who do not meet are expected to have withdrawn from the course unless they have notified a valid due date to the Student Administration, e-mail address: email@example.com.
Compulsory participation in the course must be completed and mandatory submissions must be approved to pass the exam.
As the teaching involves laboratory and/or field work, you should consider taking out a separate travel and personal risk insurance. Read about your insurance cover as a student.
Access to teaching
A student who has completed compulsory instruction and coursework and has had these approved, is not entitled to repeat that instruction and coursework. A student who has been admitted to a course, but who has not completed compulsory instruction and coursework or had these approved, is entitled to repeat that instruction and coursework, depending on available capacity.
Compulsory participation and approved assignments are valid for 3 years.
The course may be cancelled if the number of enrolled students are low.
Final written exam, 4 hours, which counts 100 % towards the finale grade.
Mini lectures, poster preparation and -presentation should be approved prior to the exam.
It will also be counted as one of the three attempts to sit the exam for this course, if you sit the exam for one of the following courses: FRM5530 – Drug Formulation, Drug Targeting
Examination support material
Casio FX-991EX calculators are handed out to all exam candidates at the beginning of the exam. You may not use your own calculator on the exam.
Language of examination
The examination text is given in Norwegian. You may submit your response in Norwegian, Swedish or Danish. English on request.
Grades are awarded on a scale from A to F, where A is the best grade and F is a fail. Read more about the grading system.
Resit an examination
This course offers both postponed and resit of examination. Read more: